PremiumCompany AnnouncementsCBA Director Howitt Increases Shareholding via Dividend Reinvestment1d ago
PremiumCompany AnnouncementsCBA Director Julie Galbo Increases Shareholding via Dividend Reinvestment Plan1d ago
PremiumRatingsAstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating2d agoAZN
AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
PremiumThe FlyAstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley2d agoAZN